BioSyent Inc.
OTC: BIOYF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- René C. Goehrum
- Employees
- 711
- Headquarters
- Mississauga, Canada
- IPO year
- 2012
- Market cap
- $113.2M
- Website
- https://www.biosyent.com
Loading BIOYF…
Loading profile data…Frequently asked questions about BIOYF
What does BioSyent Inc. (BIOYF) do?
BioSyent Inc., together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency an...
Where does BIOYF trade?
BioSyent Inc. (BIOYF) trades on the Other OTC.
What sector is BIOYF in?
BioSyent Inc. (BIOYF) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of BioSyent Inc.?
René C. Goehrum is the chief executive officer of BioSyent Inc. (BIOYF).
Where is BioSyent Inc. headquartered?
BioSyent Inc. is headquartered in Canada.
Does BIOYF pay a dividend?
Yes — BioSyent Inc. (BIOYF) paid a trailing twelve-month dividend of USD 0.15 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did BIOYF go public?
BioSyent Inc. (BIOYF) completed its initial public offering in 2012.